Funding Opportunities

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed)

RFA-CA-18-002
Application Receipt Date:
Expiration Date: January 1, 2020

New announcements are coming soon.

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trials Optional)

RFA-CA-18-010
Application Receipt Date:
Expiration Date: January 1, 2020

New announcements are coming soon.

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trials Optional)

RFA-CA-18-009
Application Receipt Date:
Expiration Date: January 1, 2020

New announcements are coming soon.

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)

RFA-CA-18-008
Application Receipt Date:
Expiration Date: January 1, 2020

New announcements are coming soon.

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trials Optional)

RFA-CA-18-007
Application Receipt Date:
Expiration Date: January 1, 2020

New announcements are coming soon.

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trials Optional)

RFA-CA-18-006
Application Receipt Date:
Expiration Date: January 1, 2020

New announcements are coming soon.

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed)

RFA-CA-18-005
Application Receipt Date:
Expiration Date: January 1, 2020

New announcements are coming soon.